Anti-CD138 chimeric antigen receptor-modified T cell therapy for multiple myeloma with extensive extramedullary involvement

被引：25
|
作者：
Tian, Chen [1 ]
Yang, Hongliang [1 ]
Zhu, Lei [1 ]
Zhang, Qing [1 ]
Cao, Zeng [1 ]
Zhang, Yizhuo [1 ]
机构：
[1] Tianjin Med Univ Canc Inst & Hosp, Natl Clin Res Ctr Canc, Key Lab Canc Prevent & Therapy, Tianjin, Peoples R China
来源：
ANNALS OF HEMATOLOGY | 2017年 / 96卷 / 08期
基金：
中国国家自然科学基金;
关键词：
D O I：
10.1007/s00277-017-3029-3
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1407 / 1410
页数：4
相关论文
共 50 条
  • [41] Targeting T-cell Leukemia with CD5-Based Chimeric Antigen Receptor-Modified γδ T Cells
    Fleischer, Lauren C.
    Zoine, Jaquelyn T.
    Ryan, Rebecca E.
    Raikar, Sunil S.
    Doering, Christopher B.
    Spencer, H. Trent
    MOLECULAR THERAPY, 2018, 26 (05) : 57 - 57
  • [42] Chimeric antigen receptor-modified T cells strike back
    Frigault, Matthew J.
    Maus, Marcela V.
    INTERNATIONAL IMMUNOLOGY, 2016, 28 (07) : 355 - 363
  • [43] Current Status of Chimeric Antigen Receptor T-Cell Therapy in Multiple Myeloma
    Jindal, Vishal
    Khoury, John
    Gupta, Ruby
    Jaiyesimi, Ishmael
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2020, 43 (05): : 371 - 377
  • [44] COMMON TRAJECTORIES OF HIGHLY EFFECTIVE ANTI-CD19 CHIMERIC ANTIGEN RECEPTOR-MODIFIED T CELLS IDENTIFIED BY ENDOGENOUS T CELL RECEPTOR LINEAGES
    Wilson, Taylor
    Kim, Hyunjin
    Crawford, Jeremy
    Chou, Ching-Heng
    Langfitt, Deanna
    Allen, E. Kaitlynn
    Lockey, Timothy
    Meagher, Michael
    Talleur, Aimee
    Gottschalk, Stephen
    Thomas, Paul
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A160 - A161
  • [45] Bispecific Chimeric Antigen Receptor T Cell Therapy for B Cell Malignancies and Multiple Myeloma
    Cronk, Robert J.
    Zurko, Joanna
    Shah, Nirav N.
    CANCERS, 2020, 12 (09) : 1 - 15
  • [46] Adoptive Therapy With Chimeric Antigen Receptor-Modified T Cells of Defined Subset Composition
    Riddell, Stanley R.
    Sommermeyer, Daniel
    Berger, Carolina
    Liu, Lingfeng
    Balakrishnan, Ashwini
    Salter, Alex
    Hudecek, Michael
    Maloney, David G.
    Turtle, Cameron J.
    CANCER JOURNAL, 2014, 20 (02): : 141 - 144
  • [47] Infectious complications of CD19-targeted chimeric antigen receptor-modified T-cell immunotherapy
    Hill, Joshua A.
    Li, Daniel
    Hay, Kevin A.
    Green, Margaret L.
    Cherian, Sindhu
    Chen, Xueyan
    Riddell, Stanley R.
    Maloney, David G.
    Boeckh, Michael
    Turtle, Cameron J.
    BLOOD, 2018, 131 (01) : 121 - 130
  • [48] Invasive Fungal Infections after Anti-CD19 Chimeric Antigen Receptor-Modified T-Cell Therapy: State of the Evidence and Future Directions
    Garner, Will
    Samanta, Palash
    Haidar, Ghady
    JOURNAL OF FUNGI, 2021, 7 (02) : 1 - 15
  • [49] Cytokine release syndrome and neurotoxicity after CD19 chimeric antigen receptor-modified (CAR-) T cell therapy
    Hay, Kevin A.
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 183 (03) : 364 - 374
  • [50] Critical factors in chimeric antigen receptor-modified T-cell (CAR-T) therapy for solid tumors
    Yan, Lingli
    Liu, Bainan
    ONCOTARGETS AND THERAPY, 2019, 12 : 193 - 204
12345